Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
Ketogenic Therapies
Medical Foods
GI
Glycomacropeptide
Medical Formula
Cystic Fibrosis
Protein Supplement
Health Care
Low Protein Foods
Nutrition
Therapeutics
Metabolic Formula
Nutritional Theraphy
Glytactin containing GMP
Intractable Epilesy
Inborn Errors of Metabolism
Protein Allergy
Fitness
Date founded
2000
Funding rounds raised
C
Cambrooke raised undisclosed on April 11, 2016
Investors: van Galen, Seventure Partners and Ruffena Capital Ltd